United Therapeutics CEO Martine A. Rothblatt reports $5.57 million common share disposal

UTHR•2026-11-12

United Therapeutics CEO Martine A. Rothblatt sold 9,500 common shares on Nov. 10, 2026, and exercised options for 9,500 shares at $117.76 apiece. The transactions left the affected trusts with 324,443 common shares and 52,910 options.

United Therapeutics CEO Martine A. Rothblatt reports $5.57 million common share disposal

1. Share transactions

Related News

American Realty Investors swings to Q3 net loss on higher expenses

iAnthus Capital Q3 revenue rises 9% year over year

Charles Schwab issues $3 billion in senior notes

Sources

United Therapeutics CEO Martine A. Rothblatt reports $5.57 million common share disposal

Aramark names Antony F. Spring to compensation and human resources, finance and technology committees

DiaMedica Therapeutics Q3 2026 net loss widens 31% to $11.31 million